These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6165129)

  • 1. Vincristine, bleomycin, methotrexate, 5-fluorouracil, and prednisone in metastatic, hormonally unresponsive prostatic adenocarcinoma.
    Paulson DF; Walker RA; Berry WR; Cox EB; Hinshaw W
    Urology; 1981 May; 17(5):443-5. PubMed ID: 6165129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report.
    Kane RD; Stocks LH; Paulson DF
    J Urol; 1977 Apr; 117(4):467-71. PubMed ID: 850320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
    Graham SD; Walker A; Cox EB; Laszlo J; Berry WR; Paulson DF
    Urology; 1986 Nov; 28(5):404-8. PubMed ID: 3538611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of hormone-unresponsive prostatic cancer and its metastatic foci].
    Kotake T
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):387-96. PubMed ID: 6764105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy trial with comp-F regimen in advanced adenocarcinoma of prostate.
    Buell GV; Saiers JH; Saiki JH; Bergreen PW
    Urology; 1978 Mar; 11(3):247-50. PubMed ID: 636128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial carcinoembryonic antigen assays in patients with metastatic carcinoma of prostate being treated with chemotherapy.
    Kane RD; Mickey DD; Paulson DF
    Urology; 1976 Dec; 8(6):559-62. PubMed ID: 997050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer].
    Kazama T; Katayama T; Umeda K; Akiya T; Nakada T
    Hinyokika Kiyo; 1986 Feb; 32(2):201-5. PubMed ID: 2425607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of skeletal metastases.
    Cadman E; Bertino JR
    Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1211-5. PubMed ID: 62744
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
    Herr HW
    J Urol; 1982 Mar; 127(3):462-5. PubMed ID: 7062419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with advanced stage D adenocarcinoma of the prostate].
    Yoshimoto J; Nasu Y; Akagi T; Obama T; Tsushima T; Ozaki Y; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1985 Jan; 76(1):1-9. PubMed ID: 2409318
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide, doxorubicin hydrochloride and 5-fluorouracil in advanced carcinoma of the prostate.
    Soloway MS; Shippel RM; Ikard M
    J Urol; 1979 Nov; 122(5):637-9. PubMed ID: 501816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
    Smalley RV; Murphy S; Huguley CM; Bartolucci AA
    Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
    Yoshimoto J; Ochi J; Tanahashi T; Nanba K; Saegusa M; Hara M; Akagi T; Obama T; Tsushima T; Ozaki Y
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB; Lindner A
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive combination chemotherapy for cancer of the oral cavity.
    Khanna NN; Srivastava PK; Khanna S; Das SN
    Cancer; 1983 Sep; 52(5):790-3. PubMed ID: 6191852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Raafat J; Oster MW
    Cancer Treat Rep; 1980 Jan; 64(1):187-9. PubMed ID: 6155209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental chemotherapy in carcinoma of the cervix.
    Papadimitriou G; Razis D; Panopoulos C; Lappas C; Gnafakis N
    Int Surg; 1974 Sep; 59(9):472-5. PubMed ID: 4137657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.